A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

Clinical trial NCT05606757 · WITHDRAWN

Trial details

NCT number: NCT05606757
Sponsor: AbbVie
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ventral Hernia Abdominal Hernia

Start date: 2024-05-07
Primary completion: 2025-04-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.